4-环己基苯硼酸 | 374538-04-2

• 物质功能分类: 化学试剂 - 有机试剂 - 硼酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-环己基苯硼酸
• 中文别名: 4-环己基苯基硼酸；4-环己烷基苯硼酸
• 英文名称: (4-cyclohexylphenyl)boronic acid
• 英文别名: 4-cyclohexylbenzeneboronic acid；4-Cyclohexylphenylboronic acid
• CAS: 374538-04-2
• 化学式: C₁₂H₁₇BO₂
• 分子量: 204.077
• InChiKey: KNQVRFYNQWNYPU-UHFFFAOYSA-N

物化性质

• 熔点：
  220°C
• 沸点：
  363.7±35.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  1.41
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2931900090
• 危险性防范说明：
  P261,P264,P271,P302+P352,P305+P351+P338,P362,P403+P233,P501
• 危险性描述：
  H315,H319,H335
• 储存条件：
  保存方法：密闭存放于阴凉、通风干燥处。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
4-Cyclohexylphenylboronic acid
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
4-Cyclohexylphenylboronic acid
Ingredient name:
CAS number: 374538-04-2

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C12H17BO2
Molecular weight: 204.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

应用广泛，4-环己基苯硼酸是一种有机中间体，不仅可用于Suzuki偶联反应，制备有机电致发光(OLED)材料，还可作为医药中间体，用于合成沙坦联苯衍生物。

上下游信息

• 上游原料

  中文名称	英文名称	CAS号	化学式	分子量
  1-溴-4-环己基苯	4-bromo(cyclohexyl)benzene	25109-28-8	C12H15Br	239.155
  4-环己基苯硼酸频那醇酯	2-(4-cyclohexylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane	820223-94-7	C18H27BO2	286.222

反应信息

• 作为反应物：
  描述：

  4-环己基苯硼酸 在 叔丁基过氧化氢 、 二茂铁 、 palladium diacetate 、 sodium carbonate 作用下， 以 癸烷 、 水 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 生成 2-cyclohexyl-9H-fluoren-9-one
  参考文献：
  名称：

  用双亚苯基平衡探索分散能供体的尺寸极限：魔术环己基

  摘要：

  我们报告了 14 个 2,2'-二取代的 9,9'-亚二亚甲基的合成作为分子平衡，用于量化各种色散能量供体之间的伦敦色散相互作用。对于所有天平，我们在 7 种有机溶剂中使用1 H NMR 在333 K 下测量了 Δ G Z/E 。对于各种烷基和芳基取代基，由于有吸引力的伦敦分散相互作用，我们通常观察到对“折叠” Z异构体的偏好。环己基取代系统在本研究中显示出最大的Z偏好，其中 Δ G Z/E = −0.6 ± 0.05 kcal mol –1在所有溶剂中，由于环己基的旋转自由度与其较大的极化率相结合，使伦敦色散相互作用最大化。另一方面，刚性和空间要求更高的取代基如叔丁基出乎意料地有利于展开的E异构体。这是由于官能团在此分子平衡中所处的相对位置较近的结果。这种接近是泡利排斥在具有大刚性取代基（叔丁基、金刚烷基和二金刚烷基）的Z异构体中增加的原因，这导致平衡向展开的E移动-形式。虽然我们能够使

  DOI：

  10.1021/acs.joc.2c02444
• 作为产物：
  描述：

  4-环己基苯硼酸频那醇酯 在 sodium periodate 作用下， 以 水 、 丙酮 为溶剂， 反应 17.0h， 以87%的产率得到4-环己基苯硼酸
  参考文献：
  名称：

  [EN] THIOPHENE AMINO ACID DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  [FR] DERIVES D'ACIDE AMINE THIOPHENIQUE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT

  摘要：

  化合物的化学式（I）中：R1和R2可以相同也可以不同，分别表示从以下选定的基团中选择的基团：氢、卤素、氰基、硝基、卤代（C1-C6）烷基、卤代（C1-C6）氧基、（C1-C6）烷基、（C2-C6）烯基、（C2-C6）炔基、-OR4、-NR4R5、-S（O）nR4、-C（O）R4、-CO2R4、-O-C（O）R4、-C（O）NR4R5、-NR5-C（O）R4、-NR5-SO2R4、-T-CN、-T-OR4、-T-OCF3、-T-NR4R5、-T-S（O）nR4、-T-C（O）R4、-T-CO2 R4、-T-O-C（O）R4、-T-C（O）NR4 R5、-T-NR5-C（O）R4、-T-NR5-SO2R4、-R6和-T-R6其中n、T、R4、R5和R6如描述中所定义；m表示0到4之间的整数；p表示0到4之间的整数；q表示0到4之间的整数；R7表示从芳基、环烷基和杂环中选择的基团，这些基团可以选择性地被取代；R8表示从羧基、（C1-C6）烷氧羰基、（C1-C7）酰基、羟基（C1-C6）烷基羰基、（C1-C6）烷氧基（C1-C6）烷基羰基、四唑基、氨基、氨基羰基和氨基（C1-C6）烷基羰基中选定的基团；其异构体及其与药用酸或碱形成的可接受的加合盐，以及用于治疗与金属蛋白酶抑制相关的病理的药物组合物。

  公开号：

  WO2005003115A1

文献信息

• [EN] NOVEL CYCLIC BENZIMIDAZOLE DERIVATIVES USEFUL ANTI-DIABETIC AGENTS<br/>[FR] NOUVEAUX DÉRIVÉS DE BENZIMIDAZOLE CYCLIQUES UTILES COMME AGENTS ANTI-DIABÉTIQUES
  申请人：MERCK SHARP & DOHME

  公开号：WO2010047982A1

  公开（公告）日：2010-04-29

  Novel compounds of the structural formula (I) are activators of AMP-protein kinase and are useful in the treatment, prevention and suppression of diseases mediated by the AMPK-activated protein kinase. The compounds of the present invention are useful in the treatment of Type 2 diabetes, hyperglycemia, Metabolic Syndrome, obesity, hypercholesterolemia, and hypertension.

  结构式（I）的新化合物是AMP-蛋白激酶的激活剂，并且在治疗、预防和抑制由AMPK激活的蛋白激酶介导的疾病方面非常有用。本发明的化合物在治疗2型糖尿病、高血糖、代谢综合征、肥胖、高胆固醇血症和高血压方面非常有用。
• Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors
  申请人：Mjalli M.M. Adnan

  公开号：US20070191385A1

  公开（公告）日：2007-08-16

  The present invention provides imidazole derivatives of Formula (I-IV), methods of their preparation, pharmaceutical compositions comprising the compounds of Formula (I-IV), and their use in treating human or animal disorders. The compounds of the invention inhibit protein tyrosine phosphatase 1B and thus can be useful for the management, treatment, control, or the adjunct treatment of diseases mediated by PTPase activity. Such diseases include Type I diabetes and Type II diabetes.

  本发明提供了式(I-IV)的咪唑衍生物，其制备方法，包含式(I-IV)化合物的药物组合物，以及它们在治疗人类或动物疾病中的应用。该发明的化合物抑制蛋白酪氨酸磷酸酶1B，因此可用于管理、治疗、控制或辅助治疗由PTPase活性介导的疾病。这些疾病包括I型糖尿病和II型糖尿病。
• Photoredox/Cobalt-Catalyzed C(sp³)–H Bond Functionalization toward Phenanthrene Skeletons with Hydrogen Evolution
  作者：Jia-Dong Guo、Xiu-Long Yang、Bin Chen、Chen-Ho Tung、Li-Zhu Wu

  DOI：10.1021/acs.orglett.0c03665

  日期：2020.12.18

  The first example of photoredox strategy for synthesis of phenanthrene skeletons through C(sp3)–H functionalization under external oxidant-free conditions is achieved. This transformation relies on the keto–enol tautomerism of 1,3 dicarbonyl moiety, i.e., the enol form of 1,3-dicarbonyl derivatives with relatively lower oxidation potential can be activated by the excited acridinium photocatalyst. The

  实现了在外部无氧化剂条件下通过C（sp 3）–H官能化合成菲骨架的光氧化还原策略的第一个例子。这种转化依赖于1,3-二羰基部分的酮-烯醇互变异构现象，即具有较低氧化电位的1,3-二羰基衍生物的烯醇形式可以通过激发的cri啶光催化剂活化。从底物上除去的电子和质子立即被钴肟催化剂捕获，从而以高至优异的产率专门提供了用于高度取代的10-菲基酚的-羰基。
• 一种铁催化羰基化合成二芳甲酮的方法
  申请人：南京师范大学

  公开号：CN106116999B

  公开（公告）日：2019-02-01

  本发明公开了一种铁催化羰基化合成二芳甲酮类化合物的方法，属于催化合成技术领域。本发明在溶剂醇或醇的水溶液中，在碱、酸和碘化物的作用下，加入铁催化剂，催化芳基卤代物、芳硼类化合物与卤仿或四卤化碳羰基源直接交叉偶联反应制备二芳甲酮类化合物。本发明的偶联反应制备二芳甲酮类化合物的方法，具有羰基源安全、廉价和易于处理；催化剂来源广泛、廉价和毒性小；反应无需配体且活性好；反应条件温和且选择性高；底物来源广泛且稳定；底物官能团相容性好且底物的适用范围广；反应介质绿色且可以循环回收。在优化的反应条件之下，目标产品分离收率高达94％。
• <i>N</i>-Iodosuccinimide and dioxygen in an air-enabled synthesis of 10-phenanthrenols under sunlight
  作者：Jia-Dong Guo、Xiu-Long Yang、Bin Chen、Chen-Ho Tung、Li-Zhu Wu

  DOI：10.1039/d1gc02185k

  日期：——

  Using a catalytic amount of N-iodosuccinimide (NIS) in combination with O2 in air, an aerobic oxidative reaction was carried out to efficiently and scalably construct a series of 10-phenanthrenols under sunlight at room temperature. Mechanistic studies reveal that H2O2 generated in situ was responsible for the conversion of I2 to IOH as a potential initiator for later catalytic cycle.

  使用催化量的N-碘代琥珀酰亚胺 (NIS) 与空气中的O 2结合，进行有氧氧化反应，以在室温下在阳光下有效且可扩展地构建一系列 10-菲酚。机理研究表明，原位产生的H 2 O 2负责将 I 2转化为 IOH，作为后期催化循环的潜在引发剂。